Sponsor Dossier
iNova Pharmaceuticals
Sponsor Dossier for iNova Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: Acupan
- Brand: AIROMIR
- Brand: ALDARA
- Brand: ALU-TAB
- Brand: Andolex-C Oral
- Brand: BETADINE
- Brand: Burnaid
- Brand: CAL
- Device (sponsor): Nasal irrigation saline solution, non-sterile
- Device (sponsor): Non-sterile scar management dressing, reusable
- Device (sponsor): Irrigation fluid, nasal
- Device (sponsor): Artificial saliva
- Device (sponsor): Adhesive strip, skin-cover
- Device (sponsor): Adhesive strip, skin-cover
About iNova
Pharmaceuticals is an Australian Private Company with ABN 13 617 871 539, registered in NSW and currently active.
Portfolio iNova
Pharmaceuticals maintains a portfolio of 66 brands on the ARTG, of which 30 are indexable brands. The company has 28 brands with Product Information on file, 7 brands with at least one PBS-listed item, 2 brands with PBAC outcomes on record, and no brands with AusPARs on record. Notable brands include Acupan, AIROMIR, ALDARA, ALU-TAB, Andolex-C Oral, BETADINE, Burnaid, CAL, CASTOR, CEPACAINE, CEPACOL, and ClindaTech.
Therapeutic focus iNova
Pharmaceuticals' portfolio spans the following therapeutic areas: — Dermatology: 14 brands — Complementary Medicine: 9 brands — Infectious Disease: 7 brands — Pain Management: 7 brands — Respiratory: 6 brands — Endocrinology: 6 brands — Neurology: 4 brands — Gastroenterology: 4 brands — Pain & Anaesthesia: 3 brands — Cardiology: 2 brands — Oncology: 2 brands — Musculoskeletal: 1 brand — Other: 1 brand
PBS footprint
Seven brands in the iNova Pharmaceuticals portfolio hold at least one PBS-listed item, with the latest PBS schedule date touched on 1 May 2026.
Regulatory activity iNova
Pharmaceuticals has 2 brands with PBAC outcomes on record, with the most recent PBAC outcome recorded on 1 November 2020. The company has no brands with AusPARs on record.